On-Site Drug Screening Services for Security and Safety Service Personnel in New York

The Security and Safety Service at the United Nations Headquarters in New York has a requirement for testing for the use of illegal drugs and controlled substances with respect to its Security Officers and Professional staff members.Each month, security personnel, including Security Officers and Professional staff members of the Service may be designated at random for testing.Services provided must strictly adhere to the Substance Abuse Mental Health Services Administration (SAMHSA) standards. Collection must occur ON-SITE at the UN Headquarters in New York. Verbal and written results must be obtained within 72 hours.Providers who could put forth a proposal for this requirement are highly encouraged to submit a quotation for an all-inclusive cost per test for the requested services to nicha.bhandhumani@un.org. Specific Requirements/Information 1) The Security and Safety Service, Division of Headquarters Security and Safety Services, Department of Safety and Security (DSS), has a requirement for testing for use of illegal drugs and controlled substances with respect to its Security Officers and Professional staff members in accordance with the mandatory programme outlined in ST/AI/2003/2. 2) Each month, up to 20 security personnel, including Security Officers and Professional staff members of the Service may be designated at random for testing. 3) Testing shall be limited to amphetamines, barbiturates, benzodiazepines, cocaine, marijuana, methadone, opiates, phencyclidine, propoxyphene and synthetic opiates as per relevant ST/AI. 4) Testing of samples for other illegal drugs and controlled substances beyond those listed in paragraph 3 above or for other purposes is strictly prohibited. 5) The certified lab shall: • Determine the creatinine conc. on every specimen • Determine the specific gravity on every specimen for which the creatinine conc. is less than 20 mg/dL • Determine the pH on every specimen • Perform tests for oxidizing adulterants on every specimen • Perform additional validity tests when the following conditions are observed: - Abnormal physical characteristics - Reactions or responses characteristic of an adulterant - Possible unidentified interference or adulterant 6) The following services, which must strictly adhere to the Substance Abuse Mental Health Services Administration (SAMHSA) standards, are therefore required: a) Ten (10) Panel Drug Screening, encompassing only the substances shown in paragraph 3 above; 7) The following procedures should be followed: a) Collection of Specimens shall follow: • Right to Privacy • Chain of Custody: Integrity, Security, and Identification • Temperature Recording • Tamper-Evident Bottle Seal b) The United Nations staff member (the donor), randomly selected for testing must identify him/herself by way of his/her United Nations ID card to the authorized personnel at the collection facility; c) The donor’s arrival time at the collection facility should be noted in a logbook and copy of the logbook shall be provided to the to the DHMOSH Medical Director together with the written results; d) The specimen collector must ensure that the donor’s name is recorded with correct spelling in the logbook as well as in all reports to be submitted to the DHMOSH Medical Director. The correct spelling must be obtained from the donor’s UN ID Card; e) The specimen collector must explain the basic collection procedures to the donor, including failure to comply with instructions or non-cooperation, constitutes a refusal to test; f) The drug screen specimens are collected using the ‘Chain of Custody’ procedures; g) Specimens must be analyzed by an FDA approved immunoassay test; h) All positive results must be confirmed by Gas Chromatography/Mass Spectrometry (GC/MS); the analytical method used must combine chromatographic separation and mass spectrometric identification (e.g., GC/MS, Liquid chromatography/mass spectrometry (LC/MS), GCMS/MS and LC/MS/MS and UPLC/HRMS). A confirmatory drug test must be validated before the laboratory can use it to test specimens. i) Verbal results must be available within 24-48 hours to the DHMOSH Medical Director, with written results to follow. j) In case a sample tests positive, it is imperative that the MRO holds consultation with the donor who tested positive to review all prescribed and non-prescribed medications ingested prior to the test being performed, if any. With the donor’s consent, any result from these consultations shall be communicated to the DHMOSH Medical Director. 8) The collection facility will be ON-SITE to be held at the UN Headquarters in New York, at pre-determined location in full compliance with the following requirements: a) A restroom or stall with a toilet for the donor to have privacy while providing the urine specimen. Whenever available, a single toilet restroom, with a full-length privacy door, is preferred. All types of restrooms including a mobile facility (e.g., a vehicle with an enclosed toilet) are acceptable. b) A source of water for washing hands that, if practical, is external to the restroom where urination occurs. If the only source of water available is inside the restroom, the donor may wash his or her hands, and then the collector must secure (e.g., use tamper-evident tape, cut off the water supply) the water source before the collection takes place. If water is not available at the collection site, the collector may provide moist towelettes outside the restroom. c) A suitable clean surface for the collector to use as a work area and for completing the required paperwork. d) A second type of facility for urination, which can be used as a collection site, is a multi-stall restroom. Such a site must provide substantial visual privacy (e.g., a toilet stall with a partial-length door) and meet all other requirements listed above (2 and 3). Additionally, if a multi-stall restroom is used, the collector must either: i) Secure all sources of water and other substances that could be used for adulteration and substitution (e.g., water faucets, soap dispensers) and place bluing agent in all toilets or secure the toilets to prevent access; or ii) Conduct all collections as monitored collections e) Note: The collector’s work area may be located outside the restroom. However, if there is no appropriate space available outside the restroom to serve as a secure, clean work area and the restroom is either a multi-stall facility or a single stall facility with a partial door for privacy, and is large enough to accommodate a work area, the collector may locate the work area inside the restroom as long as all procedures for a monitored collection are met. 9) All collection sites must meet the following security requirements by having: a) Procedures or restrictions to prevent unauthorized access to the site during the collection; b) Procedures to prevent the employee or anyone else from gaining unauthorized access to the collection materials/supplies. The collector must also ensure that the employee does not have access to items that could be used to adulterate or dilute the specimen (e.g., soap, disinfectants, cleaning agents, water); c) Procedures to ensure that all authorized persons are under the supervision of a collector or appropriate site personnel at all times when permitted into the site; and, d) Procedures to provide for the secure handling and storage of specimens. Note: The testing site is that portion of the facility where the collector performs the paperwork, seals the specimens, and where urination occurs. It does not necessarily include the total physical facility (e.g., clinic). Additionally, unauthorized personnel are any individuals that are not specifically authorized by the regulation, the collector, or employer to be present at the collection site. 10) All test results must be kept strictly confidential. Any positive results must be reported to the DHMOSH Medical Director, or such authorized designated medical physician assigned by the United Nations. 11) A formal written report must be reviewed and finalized by the facility’s licensed physician in NYS who holds a nationally recognized (USA) certification examination and has the qualification of Medical Review Officer (MRO). An MRO with expired certification cannot perform the requested tasks and analysis for UN Staff members. 12) The formal written report detailing the analysis and findings must be forwarded to the attention of the DHMOSH Medical Director, within 72 hours of receipt by the Collection Facility contractor. The MRO must be available from 9:00 am to 5:00 pm on Monday through Friday to answer any questions that the DHMOSH Medical Director may have.